Genitourinary Cancers Special Issue
Within the genitourinary cancer space, there have been many treatment advances over the past year.
As part of the “Speaking Out” series, a radiation oncologist discusses the benefits of MRI-guided stereotactic body radiation therapy.
Antibody-drug conjugates represent a paradigm shift for patients with cancer and providers.
Advertisement
Advertisement
Trending on CURE
1
Oncologist Explains What the Rasonque Approval Means for Patients With Metastatic Pancreatic Cancer
2
Chemoradiotherapy Preserves the Rectum in 78.5% of Patients at 1 Year
3
Prostate Cancer Patients Got the Same Result in Fewer Visits
4
What Do Genetics Have to Do With Lung Cancer Risk? Researchers Are Working to Find Out
5